J2930 Injection, methylprednisolone sodium succinate, up to 125 mg

Short descriptor: Methylprednisolone injection

⚠ Terminated HCPCS Level II 2026
Terminated Code
J2930 was terminated as of 2024-03-31 and should not be reported for dates of service after that date. This page is retained for historical reference.
Open J2930 in the app →

Look up J2930 alongside ICD-10-CM diagnoses, the HCPCS Table of Drugs, and the AI coding assistant.

J2930 is the HCPCS Level II code for Injection, methylprednisolone sodium succinate, up to 125 mg (2026). It belongs to Section J — Drugs Administered Other Than Oral Method. Under Medicare, its coverage status is: Special coverage instructions apply. Part B pricing methodology: Drugs.

Classification & CMS Attributes

Medicare Coverage
Special coverage instructions apply (code D)
Part B Pricing
Drugs (indicator 51)
Type of Service
Medical care
Effective Date
2024-04-01
Termination Date
2024-03-31
2026 Maintenance
No change this year

Drug Details

Drug / Substance
methylprednisolone sodium succinate
Dose / Unit
up to 125 mg
Route
Injection

See the full HCPCS Table of Drugs (J-codes).

References

Cite This Page

Reference J2930 with the canonical source and edition:

J2930 — Injection, methylprednisolone sodium succinate, up to 125 mg. ICD-10 Coding Pro (HCPCS Level II 2026). https://icd10codingpro.com/hcpcs-codes/J2930

Canonical URL: https://icd10codingpro.com/hcpcs-codes/J2930

Related Codes in Section J

Browse all HCPCS Level II sections →
Reviewed by Prajwal Shrestha, CPC, CRC
Certified Professional Coder (CPC) and Certified Risk Adjustment Coder (CRC) · AAPC Member ID 01997614 · About · Editorial policy · Content last reviewed: 2026-01-01

Get HCC Mappings, Clinical Summaries, and More

Access premium features including HCC risk adjustment, FDA drug indications, AI coding assistant, and comprehensive clinical context.

Start Free Trial